TABLE 1
FROM:
Stem and Progenitor Cells in Skeletal Muscle Development, Maintenance, and Therapy
Bruno Péault, Michael Rudnicki, Yvan Torrente, Giulio Cossu, Jacques P Tremblay, Terry Partridge, Emanuela Gussoni, Louis M Kunkel and Johnny Huard
BACK TO ARTICLETable 1. Different types of stem cells investigated
| Developmental derivation | Anatomic localization | Lineage potential | Normal physiologic function | Molecular markers | Fate of human cells transplanted into immunodeficient mice | ||
|---|---|---|---|---|---|---|---|
| M | H | ||||||
| Myoblasts | Mesoderm | Cells proliferating after the activation of the satellite cells that are attached on the muscle fibers under the basal lamina | Myogenic | Regeneration of skeletal muscle fibers in injured and diseased muscle | MyoD+ | CD56+ | Fuse with mouse muscle fibers |
| Osteogenic | Desmin+ | MyoD+ | Form satellite cells | ||||
| Myf5+ | |||||||
| Desmin+ | |||||||
| SP cells | 60% somitic | Interstitial; perhaps associated with blood vessels | Myogenic | Unknown | CD34+/– | CD34+/– | Unknown |
| 40% unknown | Sca-1+ | CD133+/– | |||||
| C-kit– | C-kit– | ||||||
| CD45– | CD45– | ||||||
| CD31+/– | |||||||
| MDSC | Unknown | Myofiber periphery closely associated to blood vessels | Myogenic | Unknown | CD34+/– | Unknown | Unknown |
| Osteogenic | Sca-1+/– | ||||||
| Hematopoietic | CD45– | ||||||
| Cardiogenic | C-Kit– | ||||||
| Chondrogenic | BCL-2+ | ||||||
| Myo-endothelial cells | Unknown | Myofiber periphery close to blood vessels | Myogenic | Unknown | Unknown | CD34+ | Regeneration of muscle fibers when transplanted into CTX-treated skeletal muscle; improvement of cardiac function when injected into infarcted hearts |
| Cardiogenic | CD144+ | ||||||
| Osteogenic | CD56+ | ||||||
| Chondrogenic | CD31+ | ||||||
| Other lineages not tested | CD45– | ||||||
| Pericytes | Mesectoderm in the head; mesoderm in the body; needs further characterization | Periphery of capillaries and microvessels in all tissues | Myogenic | Blood flow regulation |
-SMA+ | CD144– | Myogenic when transplanted into CTX-treated skeletal muscle; improvement in cardiac function when injected into infarcted hearts |
| Osteogenic | Control of angiogenesis | PDGFRB+ | |||||
| Adipogenic | CD146+ | ||||||
| Chondrogenic | NG2+ | ||||||
| Other lineages not tested | CD34– | ||||||
| CD45– | |||||||
| Mesoangioblasts | Mesoderm; walls of blood vessels | Associated with the microvessel wall | Myogenic (including smooth muscle) | Unknown | CD34+ | CD34– | Regeneration of dystrophin + muscle fibers when injected into mdx/SCID mice |
| Cardiogenic (low) | Sca-1+ | CD 133– | |||||
| Osteogenic (low) | CD31+ | CD31– | |||||
| Adipogenic | C-Kit+/– | NG2+ | |||||
| CD45– | CD45– | ||||||
| CD133+ progenitor cells | Mesoderm | Myofiber periphery close to blood vessels | Myogenic | Angiogenesis in injured tissues | CD34+/– | CD34+/– | Regeneration of muscle fibers when transplanted into dystrophic skeletal muscle and promotion of angiogenesis |
| Hematopoietic | Hematopoiesis | Sca-1+ | Thy-1+/– | ||||
| Vasculogenic (endothelium) | CD133+ | ||||||
| CD146+ | |||||||
Abbreviations: MDSC, muscle-derived stem cell; Sca-1, stem cell antigen-1; SCID, severe combined immunodeficiency; SP, side population; M, mouse; H, human; CTX, cardiotoxin.

-SMA+